Matches in SemOpenAlex for { <https://semopenalex.org/work/W2091289122> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W2091289122 endingPage "138" @default.
- W2091289122 startingPage "138" @default.
- W2091289122 abstract "1.1. The effects of ipsapirone, nefazodone, tiaspirone, BMS-20661, buspirone and gepirone on the hypothalamic-pituitary-adrenal (HPA) axis were studied. These drugs were selected because they have serontonin IA (5-HT1A) receptor-binding capability and have the potential for therapeutic activity in the treatment of major affective or anxiety disorders or both.2.2. Plasma corticosterone level was used as the end point for determining the effect of each drug on the HPA axis. Each drug increased the plasma corticosterone levels in a dose-dependent manner. The ED50 values were 0.8 mg/kg for BMS-20661, 3.5 mg/kg for gepirone, 3.9 mg/kg for buspirone, 5.3 mg/ kg for tiaspirone, 10.5 mg/kg for ipsapirone and 73.5 mg/kg for nefazodone. Ipsapirone and buspirone were more efficacious than the other four drugs.3.3. The effect of a 10-mg/kg (35 mg/kg for nefazodone) test dose of each drug reached a peak between 30 min and 1 hr, and plasma corticosterone levels generally returned to control levels after 2 hr.4.4. When the drugs were given 30 min before decapitation, in conjunction with a rotatory stress, BMS-20661 significantly inhibited the stress-induced rise, whereas ipsapirone and gepirone caused a significant increase in plasma corticosterone levels. However, when the drugs were given 2 hr before decapitation, nefazodone caused a significant decrease, whereas ipsapirone, BMS-20661 and gepirone produced significant increases in HPA axis activity. An 0800 hr dose of 0.1 mg/kg of dexamethasone suppressed the 1500 hr HPA activity by 73.1%. The 0.1-mg/kg dose of dexamethasone significantly reduced the drug-activated HPA axis activity of all of the drugs from their saline-control levels. The rank order, from least to greatest inhibitory effect, produced by this dexamethasone treatment on the drug-control levels was gepirone (−42.6%), tiaspirone (−48.9%), buspirone (−56.1%), nefazodone (−68.5%), ipsapirone (−70.0%), and BMS-20661 (−74.3%)." @default.
- W2091289122 created "2016-06-24" @default.
- W2091289122 creator A5015863731 @default.
- W2091289122 creator A5071710624 @default.
- W2091289122 creator A5076053154 @default.
- W2091289122 creator A5090568965 @default.
- W2091289122 date "1996-06-01" @default.
- W2091289122 modified "2023-09-26" @default.
- W2091289122 title "Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder" @default.
- W2091289122 doi "https://doi.org/10.1016/0924-977x(96)87941-7" @default.
- W2091289122 hasPublicationYear "1996" @default.
- W2091289122 type Work @default.
- W2091289122 sameAs 2091289122 @default.
- W2091289122 citedByCount "0" @default.
- W2091289122 crossrefType "journal-article" @default.
- W2091289122 hasAuthorship W2091289122A5015863731 @default.
- W2091289122 hasAuthorship W2091289122A5071710624 @default.
- W2091289122 hasAuthorship W2091289122A5076053154 @default.
- W2091289122 hasAuthorship W2091289122A5090568965 @default.
- W2091289122 hasConcept C126322002 @default.
- W2091289122 hasConcept C134018914 @default.
- W2091289122 hasConcept C170493617 @default.
- W2091289122 hasConcept C185592680 @default.
- W2091289122 hasConcept C2775864247 @default.
- W2091289122 hasConcept C2776134451 @default.
- W2091289122 hasConcept C2777287423 @default.
- W2091289122 hasConcept C2778362415 @default.
- W2091289122 hasConcept C2778938600 @default.
- W2091289122 hasConcept C2779419675 @default.
- W2091289122 hasConcept C2780352252 @default.
- W2091289122 hasConcept C42533223 @default.
- W2091289122 hasConcept C71315377 @default.
- W2091289122 hasConcept C71924100 @default.
- W2091289122 hasConcept C98274493 @default.
- W2091289122 hasConceptScore W2091289122C126322002 @default.
- W2091289122 hasConceptScore W2091289122C134018914 @default.
- W2091289122 hasConceptScore W2091289122C170493617 @default.
- W2091289122 hasConceptScore W2091289122C185592680 @default.
- W2091289122 hasConceptScore W2091289122C2775864247 @default.
- W2091289122 hasConceptScore W2091289122C2776134451 @default.
- W2091289122 hasConceptScore W2091289122C2777287423 @default.
- W2091289122 hasConceptScore W2091289122C2778362415 @default.
- W2091289122 hasConceptScore W2091289122C2778938600 @default.
- W2091289122 hasConceptScore W2091289122C2779419675 @default.
- W2091289122 hasConceptScore W2091289122C2780352252 @default.
- W2091289122 hasConceptScore W2091289122C42533223 @default.
- W2091289122 hasConceptScore W2091289122C71315377 @default.
- W2091289122 hasConceptScore W2091289122C71924100 @default.
- W2091289122 hasConceptScore W2091289122C98274493 @default.
- W2091289122 hasLocation W20912891221 @default.
- W2091289122 hasOpenAccess W2091289122 @default.
- W2091289122 hasPrimaryLocation W20912891221 @default.
- W2091289122 hasRelatedWork W1980346197 @default.
- W2091289122 hasRelatedWork W1984563804 @default.
- W2091289122 hasRelatedWork W2034277681 @default.
- W2091289122 hasRelatedWork W2060590717 @default.
- W2091289122 hasRelatedWork W2065448957 @default.
- W2091289122 hasRelatedWork W2075772669 @default.
- W2091289122 hasRelatedWork W2088480211 @default.
- W2091289122 hasRelatedWork W2117749122 @default.
- W2091289122 hasRelatedWork W2119923869 @default.
- W2091289122 hasRelatedWork W2214029367 @default.
- W2091289122 hasVolume "6" @default.
- W2091289122 isParatext "false" @default.
- W2091289122 isRetracted "false" @default.
- W2091289122 magId "2091289122" @default.
- W2091289122 workType "article" @default.